The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 5,444,250 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | |||
| AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 1,415,867 | 3,142,880 | SH | SOLE | 3,142,880 | 0 | 0 | |||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 24,278,800 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | |||
| ALLAKOS INC | COM | 01671P100 | 22,890,000 | 5,250,000 | SH | SOLE | 5,250,000 | 0 | 0 | |||
| ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 7,510,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| ANNEXON INC | COM | 03589W102 | 12,320,000 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | |||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 56,937,500 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | |||
| ARCELLX INC | COMMON STOCK | 03940C100 | 15,810,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 15,232,500 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 4,539,517 | 544,960 | SH | SOLE | 544,960 | 0 | 0 | |||
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 13,270,400 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | |||
| BIOGEN INC | COM | 09062X103 | 28,485,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 8,668,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 11,180,000 | 650,000 | SH | Call | SOLE | 650,000 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 5,160,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 9,472,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 53,823,000 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | |||
| DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 7,761,000 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | |||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 2,280,000 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | |||
| DELCATH SYS INC | COM NEW | 24661P807 | 6,872,328 | 1,178,787 | SH | SOLE | 1,178,787 | 0 | 0 | |||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 17,624,256 | 2,797,501 | SH | SOLE | 2,797,501 | 0 | 0 | |||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 20,025,000 | 1,780,000 | SH | SOLE | 1,780,000 | 0 | 0 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 6,267,421 | 307,076 | SH | SOLE | 307,076 | 0 | 0 | |||
| GALAPAGOS NV | SPON ADR | 36315X101 | 10,165,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| GERON CORP | COM | 374163103 | 7,062,000 | 2,200,000 | SH | SOLE | 2,200,000 | 0 | 0 | |||
| GRACELL BIOTECHNOLOGIES INC | SPONSORED ADS | 38406L103 | 6,858,000 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | |||
| ICOSAVAX INC | COM | 45114M109 | 21,505,808 | 2,165,741 | SH | SOLE | 2,165,741 | 0 | 0 | |||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 41,125,000 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | |||
| IMMATICS N.V | SHS | N44445109 | 5,770,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| IMMUNIC INC | COM | 4525EP101 | 1,057,172 | 421,184 | SH | SOLE | 421,184 | 0 | 0 | |||
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 29,980,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| IMMUNOVANT INC | COM | 45258J102 | 42,682,500 | 2,250,000 | SH | SOLE | 2,250,000 | 0 | 0 | |||
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 7,589,750 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
| KURA ONCOLOGY INC | COM | 50127T109 | 5,290,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| LIANBIO | SPONSORED ADS | 53000N108 | 638,400 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | |||
| MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 5,701,500 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | |||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 9,212,000 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | |||
| MORPHOSYS AG | SPONSORED ADS | 617760202 | 8,964,000 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | |||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 28,290,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
| NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 11,027 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | |||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 33,807,191 | 3,743,875 | SH | SOLE | 3,743,875 | 0 | 0 | |||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 4,967,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 34,356,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 16,628,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| TENAYA THERAPEUTICS INC | COM | 87990A106 | 3,522,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
| TYRA BIOSCIENCES INC | COM | 90240B106 | 542,780 | 31,872 | SH | SOLE | 31,872 | 0 | 0 | |||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 8,200,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| VIGIL NEUROSCIENCE INC | COM | 92673K108 | 1,770,866 | 188,390 | SH | SOLE | 188,390 | 0 | 0 | |||
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | 4,906,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 26,763,750 | 1,125,000 | SH | SOLE | 1,125,000 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 10,587,500 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | |||